Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase

被引:19
|
作者
Li, Q [1 ]
Kasten-Jolly, J
Yen, Y
Freed, BM
机构
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Surg, Albany, NY 12208 USA
[3] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA 91010 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Clin Immunol & Histocompatibil Lab, Dept Med, Denver, CO 80262 USA
关键词
D O I
10.1006/taap.1998.8394
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydroquinone (HQ) is a benzene derivative that is found in large quantities in cigarette tar as a result of the pyrolysis of tobacco flavinoids, HQ is a potent inhibitor of T cell proliferation causing an immediate and complete cessation of DNA synthesis in IL-2-dependent human T lymphoblasts and Jurkat T cells without loss of cell viability. Previous studies from our laboratory demonstrated that the antiproliferative effects of HQ could be partially reversed by the addition of deoxyribonucleosides, but not by the corresponding ribonucleosides, suggesting that HQ might inhibit ribonucleotide reductase, In the present study, the molecular mechanism behind this observation was further investigated. Jurkat T cells were stably transfected with a pMEP4 expression vector containing the gene for the M2 subunit of ribonucleotide reductase under transcriptional control of the human metallothionein IIA promoter. M2-transfected Jurkat T cells exhibited a greater than three-fold increase in resistance to HQ compared to untransfected cells or cells transfected with the M2 gene in the reverse orientation. HQ resistance was associated with an increased level of M2 protein detected by Western blot, These results suggest that the benzene derivative inhibits lymphocyte proliferation by inhibiting ribonucleotide reductase. (C) 1998 Academic Press.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 50 条
  • [21] Ribonucleotide reductase subunit M2 plays important role in cisplatin resistance of cancer cells
    Rahman, Mohammad Aminur
    Amin, A. R. M. R.
    Peng, Xianghong
    Zhang, Jun
    Chen, Zhuo G.
    Shin, Dong M.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] EFFECT OF GALLIUM ON THE TYROSYL RADICAL OF THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE
    NARASIMHAN, J
    ANTHOLINE, WE
    CHITAMBAR, CR
    BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) : 2403 - 2408
  • [23] Serum Ribonucleotide Reductase Subunit M2 in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma
    Jin, Xuehang
    Yu, Wei
    Wang, Ange
    Qiu, Yunqing
    LABORATORY MEDICINE, 2023, 54 (06) : 626 - 632
  • [24] Small Interfering RNA (siRNA)-Mediated Silencing of the M2 Subunit of Ribonucleotide Reductase A Novel Therapeutic Strategy in Ovarian Cancer
    Zhang, Meng
    Wang, Jing
    Yao, RuYong
    Wang, LiMing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (04) : 659 - 666
  • [25] Prognostic and predictive value of ribonucleotide reductase subunit family M1/M2 in urothelial carcinoma
    Guo, J.
    Xie, W.
    Wang, Q.
    Huang, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S593 - S594
  • [26] Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Homma, Yukio
    Fukayama, Masashi
    HISTOPATHOLOGY, 2010, 57 (06) : 885 - 892
  • [27] Increased Expression of Ribonucleotide Reductase Subunit M2 in Adrenal Cortical Carcinoma: Possible Mechanism of Chemoresistance
    Lin, J.
    Thomas, D. G.
    Giordano, T. J.
    LABORATORY INVESTIGATION, 2010, 90 : 130A - 130A
  • [28] Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
    Kim, Hee Yeon
    Kim, Chang Wook
    GUT AND LIVER, 2014, 8 (06) : 580 - 581
  • [29] Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma
    Das, Basudeb
    Jain, Neha
    Mallick, Bibekanand
    GENE, 2022, 808
  • [30] Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
    Morikawa, Teppei
    Hino, Rumi
    Uozaki, Hiroshi
    Maeda, Daichi
    Ushiku, Tetsuo
    Shinozaki, Aya
    Sakatani, Takashi
    Fukayama, Masashi
    HUMAN PATHOLOGY, 2010, 41 (12) : 1742 - 1748